Form D · Pharmaceuticals
CUTISPHARMA HOLDINGS, INC.
Raleigh, NC · CIK 0001734281
Offering snapshot reported Apr 4, 2018 · SEC filing
- Reported sold
- $69.9M Offering amount: $69.9M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 21, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 4, 2018 | Initial | $69,923,803 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-309297
$19,923,803 in securities were issued in connection with an acquisition and $50,000,000 in securities were issued for cash.
Source: Form D, filed Apr 4, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeff Edwards | Director, Executive |
| Frank Leo | Director |
| Neal Muni | Director, Executive |
| Amit Patel | Director |
| Gaetano Petrelli | Director, Executive |
| Dave Ritchie | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4208 Six Forks Road Suite 920
Raleigh, NC, 27609
Raleigh, NC, 27609